Literature DB >> 3654142

Lens protein composition, glycation and high molecular weight aggregation in aging rats.

M S Swamy1, E C Abraham.   

Abstract

Because of minimal or no turnover, lens proteins are subjected to substantial post-translational modifications which in turn disrupt lens architecture and change the optical properties leading to senile cataract formation. Progressive glycation is believed to have the potential to initiate the changes that are conducive to lens opacification. Fisher 344 rats were systematically followed from juvenile to older and aged phases of their life to study the relationship between lens glycation and high molecular weight (HMW) aggregate formation as well as quantitative and qualitative changes in lens crystallins. Levels of glycated proteins were quantified by affinity chromatography. Changes in lens crystallin composition and HMW aggregate formation were monitored by molecular sieve HPLC, further confirmed by SDS-PAGE and IEF techniques. As the age advances HMW and insoluble proteins increase with a concomitant disappearance of gamma-crystallins from soluble fraction. This disappearance of gamma-crystallins coincided with increased glycation (approximately 2-fold higher in insoluble fraction) and decreased sulfhydryl groups from soluble fraction. It appears that lens protein glycation, disappearance of gamma-crystallins and sulfhydryls from soluble fraction and increase of insoluble fraction and HMW aggregate are interrelated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654142

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

1.  Formation of advanced glycation end (AGE) products in diabetes: prevention by pyruvate and alpha-keto glutarate.

Authors:  S D Varma; P S Devamanoharan; A H Ali
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

2.  Aggregation of lens crystallins in an in vivo hyperbaric oxygen guinea pig model of nuclear cataract: dynamic light-scattering and HPLC analysis.

Authors:  M Francis Simpanya; Rafat R Ansari; Kwang I Suh; Victor R Leverenz; Frank J Giblin
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

3.  Crystallin composition of human cataractous lens may be modulated by protein glycation.

Authors:  J Ramalho; C Marques; P Pereira; M C Mota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

4.  alpha-Crystallin chaperone-like activity and membrane binding in age-related cataracts.

Authors:  Brian A Cobb; J Mark Petrash
Journal:  Biochemistry       Date:  2002-01-15       Impact factor: 3.162

Review 5.  New focus on alpha-crystallins in retinal neurodegenerative diseases.

Authors:  Patrice E Fort; Kirsten J Lampi
Journal:  Exp Eye Res       Date:  2010-11-27       Impact factor: 3.467

6.  Role of the specifically targeted lysine residues in the glycation dependent loss of chaperone activity of alpha A- and alpha B-crystallins.

Authors:  Edathara C Abraham; Jin Huaqian; Atya Aziz; Anbarasu Kumarasamy; Poppy Datta
Journal:  Mol Cell Biochem       Date:  2007-12-25       Impact factor: 3.396

7.  Alterations in lenticular proteins during ageing and selenite-induced cataractogenesis in Wistar rats.

Authors:  Muniyan Sakthivel; Rajan Elanchezhian; Philip A Thomas; Pitchairaj Geraldine
Journal:  Mol Vis       Date:  2010-03-16       Impact factor: 2.367

8.  Glycation by ascorbic acid oxidation products leads to the aggregation of lens proteins.

Authors:  Mikhail Linetsky; Ekaterina Shipova; Rongzhu Cheng; Beryl J Ortwerth
Journal:  Biochim Biophys Acta       Date:  2007-10-16

9.  Reversal of chaperone activity loss of glycated alphaA-crystallin by a crosslink breaker.

Authors:  Poppy Datta; Latha Kallur; Edathara C Abraham
Journal:  Mol Cell Biochem       Date:  2008-06-03       Impact factor: 3.396

10.  A comparative study of lens protein glycation in various forms of cataract.

Authors:  P H Anathanaryanan
Journal:  Indian J Clin Biochem       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.